Financials
- Market Capitalization 1.79 B
- Employee 14 K
- Founded 2023
- CEO Paul R. N. Kirchgraber
- Website www.fortrea.com
- Headquarter North Carolina, United States
- FIGI BBG01GZF9VY6
- Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-1.6
주가매출액비율
—
Related tickers
| # | 이름 | 가격 | 24h % | 7d % | 1M % | 1Y % | 마켓 캡 | 이전 7일 | |
|---|---|---|---|---|---|---|---|---|---|
| 2071 | SEPN Septerna, Inc. - Common Stock | 38.91 USD | -3.85% | -3.31% | +14.44% | +76.78% | 1.82 B USD | ||
| 2076 | NTLA Intellia Therapeutics, Inc. - Common Stock | 12.87 USD | -1.83% | +2.14% | +17.97% | -6.20% | 1.80 B USD | ||
| 2091 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.34 USD | -2.91% | -2.05% | +11.71% | -27.23% | 1.79 B USD | ||
| 2106 | SNDX Syndax Pharmaceuticals, Inc. - Common Stock | 19.54 USD | -3.08% | -0.76% | +1.93% | +18.42% | 1.74 B USD |